DocDollars

Dompe Farmaceutici S.P.A.

Italy · Reporting entity ID 100001351973

Total reported 2019–2025
$13.3M
#420 of 2,960 reporting companies — 0% of all reported industry payments
$225K in general payments across 108 records, plus $13.0M in research funding across 4,970 records.

How it breaks down

General payments $224,936
Research funding $13,049,684

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dompe Farmaceutici S.P.A. reported $13.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #420 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 108 general payment records and 4,970 research records were filed.

Common questions about Dompe Farmaceutici S.P.A.

How much has Dompe Farmaceutici S.P.A. paid US doctors?

Dompe Farmaceutici S.P.A. reported $13,274,620 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $224,936 in general payments, $13,049,684 in research funding.

How does Dompe Farmaceutici S.P.A. rank among drug and device companies?

It ranks #420 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Dompe Farmaceutici S.P.A. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.